Core Scientific, Valuation
| CORZ Stock | USD 17.88 0.17 0.96% |
At this time, the firm appears to be overvalued. Core Scientific, Common shows a prevailing Real Value of $10.08 per share. The current price of the firm is $17.88. Our model approximates the value of Core Scientific, Common from analyzing the firm fundamentals such as Operating Margin of 0.04 %, return on asset of 0.052, and Shares Outstanding of 258.22 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Core Scientific,'s valuation include:
Enterprise Value 3.4 B | Enterprise Value Ebitda 440.22 | Price Sales 5.0188 | Forward PE 10.0705 | Enterprise Value Revenue 5.9311 |
Overvalued
Today
Please note that Core Scientific,'s price fluctuation is moderately volatile at this time. Calculation of the real value of Core Scientific, Common is based on 3 months time horizon. Increasing Core Scientific,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Core Scientific, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Core Stock. However, Core Scientific,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17.88 | Real 10.08 | Target 6.75 | Hype 16.78 | Naive 17.74 |
The intrinsic value of Core Scientific,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Core Scientific,'s stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Core Scientific, Common helps investors to forecast how Core stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Core Scientific, more accurately as focusing exclusively on Core Scientific,'s fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Core Scientific,'s intrinsic value based on its ongoing forecasts of Core Scientific,'s financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Core Scientific,'s closest peers.
Core Scientific, Cash |
|
Core Valuation Trend
Analysing the historical paterns of Core Scientific,'s enterprise value and its market capitalization is a good way to estimate and gauge the value of Core Scientific, Common over time and is usually enough for investors to make rational market timing decisions.
Core Valuation Data Drivers
Core Revenue by Product
Core Scientific, Total Value Analysis
Core Scientific, Common is currently projected to have valuation of 3.41 B with market capitalization of 2.89 B, debt of 865.54 M, and cash on hands of 29.55 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Core Scientific, fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.41 B | 2.89 B | 865.54 M | 29.55 M |
Core Scientific, Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Core Scientific, has an asset utilization ratio of 70.55 percent. This suggests that the Company is making $0.71 for each dollar of assets. An increasing asset utilization means that Core Scientific, Common is more efficient with each dollar of assets it utilizes for everyday operations.Core Scientific, Ownership Allocation
Core Scientific, holds a total of 258.22 Million outstanding shares. Over half of Core Scientific,'s outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Core Scientific, Profitability Analysis
The company reported the previous year's revenue of 502.4 M. Net Loss for the year was (246.49 M) with profit before overhead, payroll, taxes, and interest of 0.About Core Scientific, Valuation
Our relative valuation model uses a comparative analysis of Core Scientific,. We calculate exposure to Core Scientific,'s market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Core Scientific,'s related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 142 M | 104.5 M | |
| Pretax Profit Margin | (0.49) | (0.51) | |
| Operating Profit Margin | 0.02 | 0.02 | |
| Net Loss | (0.49) | (0.52) | |
| Gross Profit Margin | 0.25 | 0.23 |
Core Scientific, Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 379.9 M | |
| Forward Price Earnings | 10.0705 |
Core Scientific, Current Valuation Indicators
Valuation refers to the process of determining the present value of Core Scientific, Common and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Core we look at many different elements of the entity such as Core's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Core Scientific,, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Core Scientific,'s valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Core Scientific,'s worth.Additional Tools for Core Stock Analysis
When running Core Scientific,'s price analysis, check to measure Core Scientific,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific, is operating at the current time. Most of Core Scientific,'s value examination focuses on studying past and present price action to predict the probability of Core Scientific,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific,'s price. Additionally, you may evaluate how the addition of Core Scientific, to your portfolios can decrease your overall portfolio volatility.